Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1972 3
1974 2
1975 1
1976 2
1977 1
1978 1
1979 5
1980 9
1981 5
1982 10
1983 4
1984 10
1985 13
1986 5
1987 8
1988 9
1989 17
1990 20
1991 14
1992 23
1993 13
1994 15
1995 7
1996 12
1997 17
1998 18
1999 18
2000 41
2001 33
2002 31
2003 29
2004 15
2005 23
2006 26
2007 18
2008 24
2009 20
2010 34
2011 44
2012 53
2013 50
2014 28
2015 43
2016 49
2017 46
2018 46
2019 46
2020 52
2021 46
2022 36
2023 41
2024 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,087 results

Results by year

Filters applied: . Clear all
Page 1
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.
Kawai T, Sun B, Yoshino H, Feng D, Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA, Kobilka TS, Coghlan MP, Willard FS, Kawabe Y, Kobilka BK, Sloop KW. Kawai T, et al. Among authors: yoshino h. Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29959-29967. doi: 10.1073/pnas.2014879117. Epub 2020 Nov 11. Proc Natl Acad Sci U S A. 2020. PMID: 33177239 Free PMC article.
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.
Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T; Japanese Circulation Society Joint Working Group. Kimura K, et al. Among authors: yoshino h. Circ J. 2019 Apr 25;83(5):1085-1196. doi: 10.1253/circj.CJ-19-0133. Epub 2019 Mar 29. Circ J. 2019. PMID: 30930428 Free article. Review. No abstract available.
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study.
Yoshinami T, Nagai SE, Hattori M, Okamura T, Watanabe K, Nakayama T, Masuda H, Tsuneizumi M, Takabatake D, Harao M, Yoshino H, Mori N, Yasojima H, Oshiro C, Iwase M, Yamaguchi M, Sangai T, Kosaka N, Tajima K, Masuda N. Yoshinami T, et al. Among authors: yoshino h. Breast Cancer. 2024 Jul;31(4):621-632. doi: 10.1007/s12282-024-01575-5. Epub 2024 Apr 20. Breast Cancer. 2024. PMID: 38642245 Free PMC article.
Pharmacokinetics of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis.
Shimizu H, Nishimura Y, Shiide Y, Akimoto M, Yashiro M, Ueda M, Hirai M, Yoshino H, Mizutani T, Kanai K, Kano O, Kimura H, Sekino H, Ito K. Shimizu H, et al. Among authors: yoshino h. Clin Ther. 2023 Dec;45(12):1251-1258. doi: 10.1016/j.clinthera.2023.09.025. Epub 2023 Nov 11. Clin Ther. 2023. PMID: 37953075 Free article. Clinical Trial.
Reply to Gaisendrees et al.
Yamasaki M, Yoshino H, Kunihara T, Akutsu K. Yamasaki M, et al. Among authors: yoshino h. Eur J Cardiothorac Surg. 2024 Jan 2;65(1):ezae002. doi: 10.1093/ejcts/ezae002. Eur J Cardiothorac Surg. 2024. PMID: 38216527 No abstract available.
Super-enhancer trapping by the nuclear pore via intrinsically disordered regions of proteins in squamous cell carcinoma cells.
Hazawa M, Ikliptikawati DK, Iwashima Y, Lin DC, Jiang Y, Qiu Y, Makiyama K, Matsumoto K, Kobayashi A, Nishide G, Keesiang L, Yoshino H, Minamoto T, Suzuki T, Kobayashi I, Meguro-Horike M, Jiang YY, Nishiuchi T, Konno H, Koeffler HP, Hosomichi K, Tajima A, Horike SI, Wong RW. Hazawa M, et al. Among authors: yoshino h. Cell Chem Biol. 2024 Apr 18;31(4):792-804.e7. doi: 10.1016/j.chembiol.2023.10.005. Epub 2023 Nov 3. Cell Chem Biol. 2024. PMID: 37924814 Free article.
Lymphatic targeting with nanoparticulate system.
Nishioka Y, Yoshino H. Nishioka Y, et al. Among authors: yoshino h. Adv Drug Deliv Rev. 2001 Mar 23;47(1):55-64. doi: 10.1016/s0169-409x(00)00121-6. Adv Drug Deliv Rev. 2001. PMID: 11251245 Review.
The role of microRNAs in bladder cancer.
Enokida H, Yoshino H, Matsushita R, Nakagawa M. Enokida H, et al. Among authors: yoshino h. Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S60-76. doi: 10.4111/icu.2016.57.S1.S60. Epub 2016 Jun 7. Investig Clin Urol. 2016. PMID: 27326409 Free PMC article. Review.
1,087 results